Latest total liabilities for 0VQA.L: $390M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Viking Therapeutics (0VQA.L) currently reports a total liabilities of $390M as of September 2026. That compares with $320K in the prior-year period — up 122090.9% year over year. Use the charts on this page to explore Viking Therapeutics's total liabilities history and peer comparisons.
Viking Therapeutics's total liabilities increased from $320K to $390M — a 122090.9% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Viking Therapeutics reported $390M in total liabilities as of September 2026. That compares with $320K in the prior-year period — up 122090.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $390M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Viking Therapeutics, and consider following 0VQA.L for alerts when major investors trade the stock.
Viking Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $390M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 0VQA.L with unrelated industries.